Loading organizations...
Veloz Bio has raised $4.0M across 1 funding round.
Key people at Veloz Bio.
Veloz Bio has raised $4.0M in total across 1 funding round.
Veloz Bio produces high-grade proteins by harnessing the metabolism of post-harvest fruits and vegetables. This innovative approach refines molecular farming, enabling rapid, decentralized, and capital expenditure-free protein expression. The technology facilitates swift protein production, scaling from nanogram to kilogram quantities within weeks, significantly accelerating manufacturing timelines.
CEO Enrique Gonzalez and his COO partner co-founded Veloz Bio, leveraging their shared background in establishing reverse logistics for discarded fruit. Their prior experience transforming agricultural waste into food ingredients led to the development of this core technology. This insight prompted the company's establishment, expanding their mission to improve the economics of valuable protein production.
Veloz Bio serves as a B2B supplier, focusing initially on high-value proteins for meat and cheese alternatives. Their α-casein production addresses a key vegan cheese market challenge, enabling products to closely mimic traditional dairy. The company’s vision is to make high-quality food ingredients more accessible through novel, scalable protein solutions.
Key people at Veloz Bio.
Veloz Bio has raised $4.0M in total across 1 funding round.
Veloz Bio's investors include Atomico, At One Ventures, Future Ventures, Kleiner Perkins, Mayfield, McWin Capital Partners, Norwest Venture Partners, SOSV, Bill Gates, Kyle Vogt, Pawan Deshpande, Richard Branson.
Veloz Bio has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in August 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 1, 2023 | $4M Seed | — | Atomico, AT ONE Ventures, Future Ventures, Kleiner Perkins, Mayfield, Mcwin Capital Partners, Norwest Venture Partners, SOSV, Bill Gates, Kyle Vogt, Pawan Deshpande, Richard Branson | Announced |
Veloz Bio is a biotechnology company specializing in animal-free protein production for egg and dairy alternatives using molecular farming with discarded fruits and vegetables. It serves food manufacturers seeking sustainable, scalable proteins like ovoalbumin, ovotransferrin, kappa-casein, and beta-casein, solving challenges in extraction, purification, regulatory hurdles for transgenic crops, and high costs/timelines of traditional methods like bioreactors or precision fermentation[1][2][3][4][6]. Their platform skips early plant growth stages, leveraging post-harvest metabolism for 100x faster production (nanogram to kilogram scale in 2 weeks vs. 10+ months for competitors) at lower costs, with zero CapEx and decentralized scaling in under 6 months; founded around 2020-2021, it has raised $275K-$4M+ and employs 2-10 people[1][3][4][5].
Veloz Bio emerged from founders with deep expertise in post-harvest processing of second/third-quality fruits and vegetables for functional food extracts, spotting an opportunity to repurpose discarded produce—nearly half of bananas and tomatoes never reach tables—into high-value proteins[1][3][7]. The idea crystallized during the IndieBio accelerator (backed by SOSV), where they validated their "moon shot" platform by producing functional proteins like casein from ugly fruit, achieving technical and economic viability at unprecedented veloz speed and scale; a pivotal moment was outcompeting peers in one week, as highlighted in IndieBio's Killer of the Week podcast on vegan cheese advancements[3]. Based in Monterrey, Mexico, the company launched without farm dependency, focusing on extraction and membrane purification to bypass bioreactors[1][2][4].
Veloz Bio rides the molecular farming wave in alt-protein biotech, transforming plants into biofactories for animal-free dairy/egg ingredients amid rising demand for sustainable food tech[3][4]. Timing aligns with food sustainability pressures—environmental/ethical issues in animal agriculture, waste from 50% post-harvest produce loss, and scalability gaps in fermentation/cultivation—positioning their zero-farm, low-cost model to disrupt economics for B2B food producers[1][3][6][7]. They influence the ecosystem by accelerating vegan innovations (e.g., cheese via casein), reducing reliance on resource-intensive methods, and enabling broader adoption through accelerators like IndieBio/SOSV, which amplify early-stage biotech impact[2][3].
Veloz Bio's platform positions it to dominate last-mile protein manufacturing for alt-dairy/egg, with pilots already underway and potential B2B expansion mirroring founders' prior ventures[3][6]. Trends like precision alt-proteins, circular economy from ag waste, and regulatory tailwinds for non-transgenic solutions will propel growth, potentially scaling to commercial volumes via partnerships. Their influence may evolve from IndieBio darling to ecosystem shaper, slashing production barriers and fueling a faster, greener protein revolution—proving discarded fruit can yield biotech gold.
